Gabelli Funds LLC lessened its stake in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) by 1.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 120,871 shares of the medical equipment provider’s stock after selling 2,000 shares during the period. Gabelli Funds LLC owned approximately 0.36% of Integer worth $10,710,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Raymond James & Associates boosted its holdings in shares of Integer by 12.6% in the 1st quarter. Raymond James & Associates now owns 40,898 shares of the medical equipment provider’s stock valued at $3,295,000 after acquiring an additional 4,578 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Integer by 1.3% in the 1st quarter. Bank of New York Mellon Corp now owns 406,645 shares of the medical equipment provider’s stock valued at $32,763,000 after acquiring an additional 5,256 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of Integer by 20.9% in the 1st quarter. American Century Companies Inc. now owns 5,573 shares of the medical equipment provider’s stock valued at $449,000 after acquiring an additional 963 shares during the last quarter. US Bancorp DE boosted its holdings in shares of Integer by 11.8% in the 1st quarter. US Bancorp DE now owns 9,970 shares of the medical equipment provider’s stock valued at $803,000 after acquiring an additional 1,051 shares during the last quarter. Finally, HighTower Advisors LLC boosted its holdings in shares of Integer by 2.9% in the 1st quarter. HighTower Advisors LLC now owns 7,831 shares of the medical equipment provider’s stock valued at $632,000 after acquiring an additional 217 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.
Insider Transactions at Integer
In other news, Director Donald J. Spence sold 6,500 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $82.32, for a total value of $535,080.00. Following the transaction, the director now directly owns 18,781 shares of the company’s stock, valued at $1,546,051.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.84% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Research Report on Integer
Integer Stock Performance
ITGR opened at $89.57 on Tuesday. The firm’s fifty day simple moving average is $80.36 and its two-hundred day simple moving average is $83.17. The company has a quick ratio of 1.86, a current ratio of 3.00 and a debt-to-equity ratio of 0.65. The company has a market cap of $2.99 billion, a price-to-earnings ratio of 36.56, a PEG ratio of 1.22 and a beta of 1.10. Integer Holdings Co. has a 52-week low of $61.85 and a 52-week high of $96.17.
Integer (NYSE:ITGR – Get Free Report) last posted its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.22. The firm had revenue of $404.69 million for the quarter, compared to the consensus estimate of $376.70 million. Integer had a net margin of 5.30% and a return on equity of 10.27%. The company’s revenue for the quarter was up 18.1% on a year-over-year basis. During the same period last year, the firm posted $0.95 earnings per share. Equities analysts anticipate that Integer Holdings Co. will post 4.59 earnings per share for the current fiscal year.
Integer Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.
Recommended Stories
- Five stocks we like better than Integer
- What is the Shanghai Stock Exchange Composite Index?
- Safeguard your portfolio with these three bargain stocks
- Want to Profit on the Downtrend? Downtrends, Explained.
- Membership clubs gain leverage for the consumer rebound
- Stock Market Sectors: What Are They and How Many Are There?
- Advanced Auto Parts may be worth more in pieces than the whole
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.